Once-daily dosing of lopinavir/ritonavir (Kaletra) receives FDA approval
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
AIDS patient care and STDs - 24(2010), 6 vom: 07. Juni, Seite 395 |
| Sprache: |
Englisch |
|---|
| Themen: |
2494G1JF75 |
|---|
| Anmerkungen: |
Date Completed 04.10.2010 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM199076251 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM199076251 | ||
| 003 | DE-627 | ||
| 005 | 20231223213935.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2010 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0664.xml |
| 035 | |a (DE-627)NLM199076251 | ||
| 035 | |a (NLM)20575157 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Once-daily dosing of lopinavir/ritonavir (Kaletra) receives FDA approval |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.10.2010 | ||
| 500 | |a Date Revised 21.11.2013 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a News | |
| 650 | 7 | |a Anti-HIV Agents |2 NLM | |
| 650 | 7 | |a HIV Protease Inhibitors |2 NLM | |
| 650 | 7 | |a Pyrimidinones |2 NLM | |
| 650 | 7 | |a Lopinavir |2 NLM | |
| 650 | 7 | |a 2494G1JF75 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t AIDS patient care and STDs |d 1996 |g 24(2010), 6 vom: 07. Juni, Seite 395 |w (DE-627)NLM09547725X |x 1557-7449 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2010 |g number:6 |g day:07 |g month:06 |g pages:395 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2010 |e 6 |b 07 |c 06 |h 395 | ||